Jacobsen Capital Management’s Pfizer PFE Stock Holding History

Jacobsen Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Sell	10,451 -529	-5%	-$13.8K	0.07%	102
2026 Q1	$308K	Buy	10,980 +337	+3%	+$8.97K	0.1%	83
2025 Q4	$265K	Buy	10,643 +503	+5%	+$12.7K	0.09%	92
2025 Q3	$258K	Buy	+10,140	New	+$250K	0.09%	94
2025 Q2	–	Sell	-9,715	Closed	-$246K	–	122
2025 Q1	$246K	Buy	9,715 +1,033	+12%	+$27K	0.11%	83
2024 Q4	$230K	Sell	8,682 -1,733	-17%	-$47K	0.1%	82
2024 Q3	$301K	Buy	10,415 +120	+1%	+$3.5K	0.13%	63
2024 Q2	$288K	Buy	+10,295	New	+$283K	0.13%	65
2024 Q1	–	Sell	-7,661	Closed	-$221K	–	94
2023 Q4	$221K	Buy	+7,661	New	+$232K	0.11%	77

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jacobsen Capital Management's PFE Position: Q2 2026 in Review

Jacobsen Capital Management reduced its Pfizer (PFE) stake by 4.8% in Q2 2026, selling an estimated $13.8K and leaving 10,451 shares worth $252K. The position accounts for 0.07% of the portfolio, ranked #102.

Jacobsen Capital Management first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $308K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Jacobsen Capital Management held 10,451 shares of Pfizer worth $252K as of Q2 2026.
Jacobsen Capital Management sold 529 Pfizer shares in Q2 2026, an estimated $13.8K.
Pfizer made up 0.07% of Jacobsen Capital Management's portfolio in Q2 2026, its #102 holding.
Jacobsen Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
Jacobsen Capital Management's Pfizer position peaked at $308K in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jacobsen Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.